2024 Coding Reference
Molecular Diagnostics
Download this page as PDF
Adenovirus
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Lyra® Adenovirus |
Nasal Swab |
87798 |
76070-2
|
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
CCI
MUE
|
$ 35.09 |
Bordetella
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Solana® Bordetella Complete |
Nasopharyngeal Swab |
87798 |
90441-7
|
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
CCI
MUE
|
$ 35.09 |
|
87798-59 |
|
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
CCI
MUE
|
$ 35.09 |
|
|
|
If all tests are ordered, performed, and reported: |
|
$ 70.18
|
Coronavirus
FAQs about the FFCRA and CARES Acts
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Lyra SARS CoV-2 |
|
87635 |
94559-2
|
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique |
CCI
MUE
|
$ 51.31 |
Lyra Direct SARS CoV-2 |
|
87635 |
94559-2
|
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique |
CCI
MUE
|
$ 51.31 |
Solana® SARS-CoV-2 Assay |
|
87635 |
94559-2
|
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique |
CCI
MUE
|
$ 51.31 |
Gastrointestinal
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Lyra Direct C. difficile |
Unformed stool |
87493 |
80685-1
|
Clostridium difficile, toxin gene(s), amplified probe technique |
CCI
MUE
|
$ 37.27 |
Solana C. difficile |
Unformed stool |
87493 |
54067-4
|
Clostridium difficile, toxin gene(s), amplified probe technique |
CCI
MUE
|
$ 37.27 |
Group B Strep
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Solana GBS |
Vaginal/Rectal Swab |
87077 |
91875-5
|
Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate |
CCI
MUE
|
$ 8.08 |
|
87653 |
|
Streptococcus, group B, amplified probe technique |
CCI
MUE
|
$ 35.09 |
|
|
|
If all tests are ordered, performed, and reported: |
|
$ 43.17
|
HSV/VZV
Please click here for HSV/VZV coding information.
Influenza
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Lyra Influenza A+B |
Nasopharyngeal Swab
Nasal Swab |
87502 |
48509-4
|
influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types |
CCI
MUE
|
$ 95.80 |
Solana Influenza A+B |
Nasopharyngeal Swab
Nasal Swab |
87502 |
48509-4
|
influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types |
CCI
MUE
|
$ 95.80 |
Solana Influenza A+B with Solana RSV + hMPV |
Nasopharyngeal Swab
Nasal Swab |
87631 |
80602-6
|
respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets |
CCI
MUE
|
$142.63 |
Parainfluenza Virus
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Lyra Parainfluenza Virus |
Nasal Swab
Nasopharyngeal Swab |
87631 |
60254-0
|
respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets |
CCI
MUE
|
$142.63 |
RSV + hMPV
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Lyra RSV + hMPV |
Nasal Swab
Nasopharyngeal Swab |
87634 |
92881-2
|
respiratory syncytial virus, amplified probe technique |
CCI
MUE
|
$ 70.20 |
|
87798-59 |
|
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
CCI
MUE
|
$ 35.09 |
|
|
|
If all tests are ordered, performed, and reported: |
|
$105.29
|
Solana RSV + hMPV |
Nasal Swab
Nasopharyngeal Swab |
87634 |
92881-2
|
respiratory syncytial virus, amplified probe technique |
CCI
MUE
|
$ 70.20 |
|
87798-59 |
|
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
CCI
MUE
|
$ 35.09 |
|
|
|
If all tests are ordered, performed, and reported: |
|
$105.29
|
Solana RSV + hMPV with Solana Influenza A+B |
Nasal Swab
Nasopharyngeal Swab |
87631 |
80602-6
|
respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets |
CCI
MUE
|
$142.63 |
Strep A
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Lyra Direct Strep |
Throat Swab |
87651 |
60489-2
|
Streptococcus, group A, amplified probe technique |
CCI
MUE
|
$ 35.09 |
|
87798 |
|
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
CCI
MUE
|
$ 35.09 |
|
|
|
If all tests are ordered, performed, and reported: |
|
$ 70.18
|
Solana GAS |
Throat Swab |
87651 |
60489-2
|
Streptococcus, group A, amplified probe technique |
CCI
MUE
|
$ 35.09 |
Solana Strep Complete |
Throat Swab |
87651 |
|
Streptococcus, group A, amplified probe technique |
CCI
MUE
|
$ 35.09 |
|
87798 |
49610-9
|
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
CCI
MUE
|
$ 35.09 |
|
|
|
If all tests are ordered, performed, and reported: |
|
$ 70.18
|
Trichomonas
Test Name |
|
CPT Code |
LOINC Code(s) |
CPT Code Description |
National Medicare Coverage |
Medicare Reimbursement |
Solana Trichomonas |
Vaginal Swab/Urine |
87661 |
69937-1
|
Trichomonas vaginalis, amplified probe technique |
CCI
MUE
|
$ 35.09 |
For Medicare Clinical Laboratory Fee Schedule, go to www.cms.hhs.gov.
*QW modifier is added to report use of CLIA-waived test system(s) for Medicare/Medicaid claims.
CMS has set the effective date for the addition of the QW modifier with 87420 and 87430 as October 6, 2020 and an implementation date of July 6, 2021. That means Medicare/Medicaid have until July 6, 2021 to update their systems to accept the QW modifier with these codes. We recommend customers check with their payers prior to submitting claims to verify if their system has been updated.
Effective January 1, 2010, CPT 81025 DOES NOT require a QW modifier to be recognized as a waived test. Source: CMS Job Aid 6685.
This information is being provided as a reference, for informational purposes only, with no expressed or implied warranty and does not purport to provide legal or certified coding advice. Under Federal and State law, it is the individual provider's responsibility to determine appropriate coding, charges and claims for a particular service. Policies regarding appropriate coding and payment levels can vary greatly from payer to payer and change over time. Quidel Corporation strongly recommends that providers contact their contracted payers to determine appropriate coding and charge or payment levels prior to submitting claims.
The information contained in this website has been compiled by CodeMap, L.L.C. who remains solely responsible for its content. The information provided is for general educational purposes only and may not be conclusive or exhaustive. Reimbursement information does not indicate overage for these services. While every effort is made to ensure that all payment amounts and regulatory information is current and complete, it is the responsibility of each user to verify specific coverage and payment information with their Medicare contractors. Actual reimbursement for healthcare facilities will vary depending on local carrier coverage and payment policies. Recent changes in applicable law, regulations and interpretations may not be reflected in the information contained herein.
This website is a private website and is not associated, endorsed or authorized by the Department of Health and
Human Services, the Center for Medicare and Medicaid Services or any other public or government organization or agency.
CPT copyright 2023 American Medical Association. All rights reserved.
This material contains content from LOINC (http://loinc.org). LOINC is copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
CodeMap® is a Registered Trademark of Wheaton Partners, LLC.
|
12/07/2024 02:55:09 18.97.14.81
|